mobile

News

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

Digital

Heads of innovation, communication and digital strategy in pharma reflected at Frontiers Health 2018 on the implications of technological changes.

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.